Toumai endoscopic
Built by MicroPort MedBot (Group) · China
The Toumai endoscopic is a Surgical / Medical robot developed by MicroPort MedBot (Group) (China), launched 2014. Key specifications: procedures laparoscopy, urology, endoscopy, tremor filtering Yes, imaging compat. 3D endoscopic vision, fda year true.
Robo Index
Weak evidence
5 of 10 signals present
Recomputed nightly from public data. Missing data is skipped, never zero-filled — and rankings are never for sale.
Weighted factors
average of the 5 scored · blanks don't count
Will it fit your job?
Tell us the job in plain words — we'll show how this robot measures up, line by line.
Tell us what your job needs — payload, budget, region, must-have certifications — and we'll show how Toumai endoscopic measures up, requirement by requirement. The Robo Index (trust) above is shown for every buyer, regardless.
Overview
Toumai is an endoscopic surgical robot developed by MicroPort MedBot for laparoscopic, urology, and general surgery procedures. It features a remote surgery capability and has received regulatory clearance in multiple countries including FDA-IDE approval. The system is designed for large-volume deployments and has achieved 100 cumulative global orders with nearly 80 installations. It includes a growing international training ecosystem and is expanding into a platform for collaborative, cross-border surgical innovation.
Flagship features
- Achieved 100 cumulative global orders; nearly 80 installations completed
- Second endoscopic surgical robot globally to scale large-volume deployments
- Gained access in over 60 countries/regions across Asia, Europe, Africa, North America, South America, Oceania; active installations in nearly 40 countries
- First surgical robot to receive regulatory approval for commercial remote surgery (April 2025)
- FDA-IDE-approved remote surgery completed in Orlando, Florida (world's first)
- Europe: Gemelli Hospital (Italy) over 50 cases; AZ Delta (Belgium) 100 cases in 10 weeks, Europe's first remote surgery
Buyer decision signals
Deployments
IRCAD
Viability
DFVision imaging system received CE mark
Specifications
Category: Surgical / Medical- Procedures
- laparoscopy, urology, endoscopy
- Tremor filtering
- Yes
- Imaging compat.
- 3D endoscopic vision
- FDA year
- true
- CE mark year
- true
- Pricing model
- purchase
Company profile
- Founded
- 2015
Detailed specifications
Other3
- Sub Category
- surgical_assistant
- Company Country
- CN
- Additional Information
- - Achieved 100 cumulative global orders; nearly 80 installations completed. - Second endoscopic surgical robot globally to scale large-volume deployments. - Gained access in over 60 countries/regions across Asia, Europe, Africa, North America, South America, Oceania; active installations in nearly 40 countries. - First surgical robot to receive regulatory approval for commercial remote surgery (April 2025). - FDA-IDE-approved remote surgery completed in Orlando, Florida (world's first). - Europe: Gemelli Hospital (Italy) over 50 cases; AZ Delta (Belgium) 100 cases in 10 weeks, Europe's first remote surgery. - Middle East: Deployed at Cleveland Clinic Abu Dhabi. - Africa: 4 installations in Morocco, over 500 surgeries performed. - South Asia: Kokilaben Hospital (India) 50+ urology procedures in first month. - Southeast Asia: Rajavithi Hospital (Thailand) designated as official national training center. - Latin America: Hospital Nove de Julho (Brazil) completed region's first commercial remote human surgery. - International training ecosystem: ORSI, IRCAD (Europe); Turkey (MENA hub); Brazil (Latin America hub); Thailand - Ministry of Health partnership. - Hybrid strategy: global academic partnerships + targeted commercialization + agile regional support. - MicroPort MedBot also has orthopedic, vascular intervention, natural orifice surgery, and percutaneous puncture robots; cumulative orders for all systems exceed 170 units. - Company founded 2015, listed on HKEX (02252.HK), subsidiary of MicroPort Scientific (00853.HK). - Pricing: enterprise pricing likely; no public price listed.
Who runs it· deployment evidence
1 on record · none maker-verified yet. Each links to its source — open it and judge.
- IRCAD· Francesource ↗
Where to buy
Get a price or reach an authorized seller — pick your region, then request a quote.
No authorized seller is listed for this robot yet — request a quote below and we’ll connect you with MicroPort MedBot (Group) Co., Ltd. or an authorized seller.
Request a quote — goes straight to MicroPort MedBot (Group) Co., Ltd..
Every authorized seller serving your region is shown equally — placement is never sold, and this data never affects a robot’s score. A seller’s absence here doesn’t mean they aren’t authorized.
Company milestones
- Nov 2025MilestoneDFVision imaging system received CE mark
- Oct 2025Milestone100 global commercial orders reached
- May 2025LaunchNMPA approval for commercial telesurgery
- Mar 2024DeploymentR-ONE performed complex vascular procedures at NICVD
- Feb 2024LaunchR-ONE received approval in China
- Dec 2023LaunchR-ONE approved by NMPA for market launch
- Jul 2023DeploymentFirst 5G ultra-remote robotic PCI with R-ONE
- Nov 2021MilestoneHKEX listing
Compare with peers
More by MicroPort MedBot (Group)
Frequently asked questions
- Who makes the Toumai endoscopic?
- The Toumai endoscopic is developed by MicroPort MedBot (Group), based in China.
- What type of robot is the Toumai endoscopic?
- The Toumai endoscopic is a Surgical / Medical robot made by MicroPort MedBot (Group).
- How much does the Toumai endoscopic cost?
- Pricing for the Toumai endoscopic is not publicly listed — contact MicroPort MedBot (Group) for a quote.
- When was the Toumai endoscopic launched?
- The Toumai endoscopic was launched in 2014.
- What are the key specifications of the Toumai endoscopic?
- Key specifications of the Toumai endoscopic: procedures laparoscopy, urology, endoscopy, tremor filtering Yes, imaging compat. 3D endoscopic vision, fda year true, ce mark year true.
Reviews for Toumai endoscopic
Loading reviews…
